| ASD | antiseizure drug |
| MES test | maximal electroshock seizure test |
| 6 Hz test | 6 Hertz test |
| scPTZ test | subcutaneous pentylenetetrazole test |
| ivPTZ test | intravenous pentylenetetrazole test |
| ADME-Tox | Absorption Distribution Metabolism Elimination and Toxicology |
| PILO | pilocarpine |
| PILO-induced SE | pilocarpine induced status epilepticus |
| DCC | (N,N′-dicyclohexylcarbodiimide) |
| TFA | trifluoroacetic acid |
| HMDS | hexamethyldisilazane |
| MW | molecular weight |
| Log P | lipholicity values |
| HBD | hydrogen bond donors |
| HBA | hydrogen bond acceptors |
| NBR | number of rotatable bonds |
| TPSA | topological polar surface area |
| LIPO | lipophilicity |
| POLAR | polarity |
| INSOLU | solubility |
| FLEX | flexibility |
| INSATU | saturation of the molecule |
| CNS | central nervous system |
| MPO | multiparameter optimization |
| GI | gastrointestinal |
| HIA | human intestinal absorption |
| BBB | blood-brain barrier |
| PGP+/− | poliglicoprotein |
| ED50 | effective dose |
| TD50 | Toxicity dose |
| SD | Standard Deviation |
| TI | Therapeutic Index |
| VPA | valproic acid |
| i.p. | intraperitoneal injection |
| GABAA | γ-aminobutyric acid A |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| NMDA | N-methyl-D-aspartic acid |
| hERG | human ether-à-go-go-related gene |
| TRPV1 | Transient receptor potential vanilloid 1 |
| VR1 | Vanilloid type 1 receptor |
| 5-HT1A | serotonin 1A |
| GAT-1 | GABA transporter 1 |
| SV2A | synaptic Vesicle Glycoprotein 2A |
| PAMPA | parallel artificial membrane permeability |
| HLMs | Human liver microsomes |
| CYP3A4 | Cytochrome P450 3A4 |
| CYP2D6 | Cytochrome P450 2D6 |
| HepG2 | Hepatoblastoma cell line |
| SH-SY5Y | Human Neuroblastoma cell line |